This is a working overview of TB-500, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-06. Anything still debated is marked as such rather than presented as settled.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
A computer expert was ultimately able to retrieve much of the data that Kidder had lost on her laptop. In a 2000 interview, Kidder stated that, in addition to causing emotional distress, her manic episodes had led her to experiencing significant financial woes: "I went through millions of dollars—I have no idea how much. I'd buy things for friends, take people to Paris. Once I stayed up for three weeks in a row because I felt like I was called upon to write a new religion for women. I was reading all these books, including the Bible—and I'm an atheist."
Portal was singled out for praise by reviewers. Official Xbox Magazine admired its unique puzzle gameplay mechanics, stating that it was the first major advance in puzzle gaming "since Russians started dropping blocks", referring to Tetris. The Escapist's Ben "Yahtzee" Croshaw stated in his Zero Punctuation review that he could not think of any criticism for Portal, saying that it had "some of the funniest pitch-black humor [he had] ever heard in a game" and concluded that it is "absolutely sublime from start to finish." The PlayStation 3 version's critical review scores suffered because of the technical issues first uncovered by 1UP.com. While discussing the retail version on a podcast, 1UP.com staff members agreed that a significant number of the frame rate problems had been resolved, but not all of them. They concluded that the PlayStation 3 version was not quite as smooth as the Xbox 360 version and recommended that "if you own both [consoles], you should do the 360" version. Kotaku's Michael McWhertor echoed that recommendation, though stated that those who only have a PlayStation 3 should still consider The Orange Box. While frame rate issues were the main complaint, the PlayStation 3 version was also criticized for unreliable voice chat and excessive network delay or lag in Team Fortress 2, as well as long load times generally. It was, however, praised for featuring anti-aliasing and a quick-save feature, neither of which were present in the Xbox 360 version (but were present in the PC version).
Amane Waseda reported δD of oil samples in northeast Japan to increase from around −130‰ to around −110‰ with higher maturity. At low thermal maturity, dos Santos Neto and Hayes reported δD of saturate fraction of oil in Portiguar Basin derived from a lacustrine environment is -90‰, and from a marine-evaporitic environment is -120‰ to −135‰. Bulk analysis of oil, which yields a complex mixture of organic compounds, obscures much of the valuable information. Switching to compound-specific study greatly expanded our understanding of hydrogen isotopes of oil. Analyzing HIC at the compound level avoids problems from differences in exchange rates, simplifies sources and products relationships, and draws a much more detailed picture. δDs of n-alkanes are generally thought to be representative of oil as they are the major components. Schimmelmann et al. confirmed that alkane fractions have almost the same DHRs as whole oils. Depending on source material type and maturity, δD of n-alkanes can vary from −100‰ to −180‰. A common phenomenon of various oil and matured rock derived n-alkanes is a trend of increasing δD with chain length. For example, Li et al. analyzed oils from the Western Canada Sedimentary Basin and found δD increased between 20‰ and 40‰ from C13 to C27. This "isotope slope" is an artifact of kinetic fractionation associated with thermal cracking of carbon chains. This trend has been experimentally reproduced and theoretically modeled by Tang et al. N-alkanes are also known to preserve detailed information of source material. Li et al.
The Cortes also passed the Habeas corpus law, the freedom of assembly law, the foreigners law and the Trade Union Freedom law. The most controversial was the abortion law, passed in the spring of 1985, and which provoked the mobilization of Catholic sectors in defense of the "right to life". Alianza Popular appealed it before the Constitutional Court, but the latter ruled in favor of it. Also controversial and the subject of an appeal before the Constitutional Court was the modification of the system of election of the members of the General Council of the Judiciary contained in the Organic Law of the Judiciary, but again the court ruled in favor of the law. As for the "regional issue", in addition to the approval of the few remaining autonomy statutes, an enormous decentralization of public spending took place, with the transfer to the autonomous communities of the powers determined by their respective statutes. By 1988, the average expenditure of the autonomous communities had already reached 20% of total public spending, and since then it has continued to increase. However, both the government of the Basque Country, presided since 1984 by "peneuvist" José Antonio Ardanza and that of Catalonia, presided since 1980 by the leader of CiU Jordi Pujol, continued to demand greater levels of self-government and opposed the "leveling" of all the autonomous communities, also accusing the government of curtailing their competences by resorting to organic laws.
Sources: en.wikipedia.org
The country declined several international offers of COVID-19 vaccines, making it one of the few countries not to begin a vaccination programme. North Korea began administering its first vaccine doses in late May 2022 to select soldiers. In May 2022, the Korean Central News Agency reported that an unspecified number of people in the capital Pyongyang tested positive for the virus, and announced the country's first confirmed deaths. Authorities announced over 1 million North Koreans were suffering from "fever". Kim Jong Un declared a national emergency and a country-wide lockdown. While NK News asserted that "fever" was used as a substitute for COVID-19 cases, the South Korean National Intelligence Service stated that the total included cases of waterborne diseases, such as measles and typhoid. In a discreet interview with the BBC through Daily NK, some North Koreans reported an alarming rate of food scarcity, as the country had stopped importing food supplies due to the pandemic. One woman reported her neighbours had died of starvation, and others said they were living in constant fear of death. On 5 May 2023, the World Health Organization (WHO) announced an end to the COVID-19 global health emergency.
Reddy's path into new drug discovery involved targeting specialty generics products in western markets to create a foundation for drug discovery. Development of specialty generics was an important step for the company's growing interest in the development of new chemical entities. The elements involved in creating a specialty generic, such as innovation in the laboratory, developing the compound, and sending the sales team to the market, are also stages in the development of a new specialty drug. Starting with specialty generics allowed the company to gain experience with those steps before moving on to creating brand-new drugs. Reddy's invested heavily in establishing R&D labs and is the only Indian company to have significant R&D being undertaken overseas. Dr. Reddy's Research Foundation was established in 1992 and in order to do research in the area of new drug discovery. At first, the foundation's drug research strategy revolved around searching for analogues. Focus has since changed to innovative R&D, hiring new scientists, especially Indian students studying abroad on doctoral and post-doctoral courses. In 2000, the Foundation set up an American laboratory in Atlanta, dedicated to discovery and design of novel therapeutics. The laboratory is called Reddy US Therapeutics Inc (RUSTI) and its main aim is the discovery of next-generation drugs using genomics and proteomics. Reddy's research thrust focused on large niche areas in western markets – anti-cancer, anti-diabetes, cardiovascular and anti-infection drugs.
==== Other forms ==== Chitosan can be directly applied to the wound as a hemostatic agent, in granule and powder forms. They are typically salts made from mixing chitosan with an organic acid (such as succinic or lactic acid). One example is Celox granules, US approved 2006. WoundStat (FDA approved, date unknown) is a granule consisting of chitosan within silica (smectite) and polyacrylic acid. It is a combination of different topical hemostatics, mineral and organic.
Sources: en.wikipedia.org
=== Engineered === Engineered nanomaterials have been deliberately engineered and manufactured by humans to have certain required properties. Legacy nanomaterials are those that were in commercial production prior to the development of nanotechnology as incremental advancements over other colloidal or particulate materials. They include carbon black and titanium dioxide nanoparticles.
=== Initiation === RNA polymerase binding in bacteria involves the sigma factor recognizing the core promoter region containing the −35 and −10 elements (located before the beginning of sequence to be transcribed) and also, at some promoters, the α subunit C-terminal domain recognizing promoter upstream elements. There are multiple interchangeable sigma factors, each of which recognizes a distinct set of promoters. For example, in E. coli, σ70 is expressed under normal conditions and recognizes promoters for genes required under normal conditions ("housekeeping genes"), while σ32 recognizes promoters for genes required at high temperatures ("heat-shock genes"). In archaea and eukaryotes, the functions of the bacterial general transcription factor sigma are performed by multiple general transcription factors that work together. The RNA polymerase-promoter closed complex is usually referred to as the "transcription preinitiation complex." After binding to the DNA, the RNA polymerase switches from a closed complex to an open complex. This change involves the separation of the DNA strands to form an unwound section of DNA of approximately 13 bp, referred to as the "transcription bubble". Supercoiling plays an important part in polymerase activity because of the unwinding and rewinding of DNA. Because regions of DNA in front of RNAP are unwound, there are compensatory positive supercoils. Regions behind RNAP are rewound and negative supercoils are present.
== Signs and symptoms == About 96% of individuals with AD present with severe pain that had a sudden onset. The pain may be described as a tearing, stabbing, or sharp sensation in the chest, back, or abdomen. About 17% of individuals feel the pain migrate as the dissection extends down the aorta. The location of pain is associated with the location of the dissection. Anterior chest pain is associated with dissections involving the ascending aorta, while interscapular (between the scapula bones in the back) back pain is associated with descending aortic dissections. If the pain is pleuritic in nature, it may suggest acute pericarditis caused by bleeding into the sac surrounding the heart. This is particularly dangerous, suggesting that acute pericardial tamponade may be imminent. Pericardial tamponade is the most common cause of death from AD. While the pain may be confused with that of a heart attack, AD is usually not associated with the other suggestive signs, such as heart failure and ECG changes. Less common symptoms that may be seen in the setting of AD include congestive heart failure (7%), fainting (9%), stroke (6%), ischemic peripheral neuropathy, paraplegia, and cardiac arrest. If the individual fainted, about half the time it is due to bleeding into the pericardium, leading to pericardial tamponade. Neurological complications of aortic dissection, such as stroke and paralysis, are due to the involvement of one or more arteries supplying portions of the brain.
This resulted in the publication of the report, The Double Bind: The Price of Being a Minority Woman in Science (1976) which made recommendations for recruiting and retaining minority women scientists. Daly was a member of the board of governors of the New York Academy of Sciences for two years. She was a fellow of the American Association for the Advancement of Science and of the American Cancer Society. Daly was designated as a career scientist by the Health Research Council of the City of New York. Daly retired in 1986 from the Albert Einstein College of Medicine, and in 1988 established a scholarship for African American chemistry and physics majors at Queens College in memory of her father. In 1999, she was recognized by the National Technical Association as one of the top 50 women in Science, Engineering and Technology.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.